See more : Livero Inc. (9245.T) Income Statement Analysis – Financial Results
Complete financial analysis of NeuroScientific Biopharmaceuticals Limited (NSB.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NeuroScientific Biopharmaceuticals Limited, a leading company in the Biotechnology industry within the Healthcare sector.
- Arich Enterprise Co., Ltd. (4173.TWO) Income Statement Analysis – Financial Results
- Palm Jewels Limited (PALMJEWELS.BO) Income Statement Analysis – Financial Results
- Mountain Province Diamonds Inc. (MPVDF) Income Statement Analysis – Financial Results
- Fiesta Restaurant Group, Inc. (FRGI) Income Statement Analysis – Financial Results
- Data Applications Company, Limited (3848.T) Income Statement Analysis – Financial Results
NeuroScientific Biopharmaceuticals Limited (NSB.AX)
About NeuroScientific Biopharmaceuticals Limited
NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. The company was incorporated in 2002 and is based in Cottesloe, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 4.95M | 0.00 | 958.77K | 0.00 | 33.85K | 28.88K | 38.03K | 116.00K |
| Cost of Revenue | 91.34K | 57.85K | 64.92K | 61.41K | 56.66K | 55.21K | 42.98K | 9.89K | 0.00 |
| Gross Profit | -91.34K | 4.90M | -64.92K | 897.36K | -56.66K | -21.36K | -14.11K | 28.13K | 116.00K |
| Gross Profit Ratio | 0.00% | 98.83% | 0.00% | 93.60% | 0.00% | -63.09% | -48.85% | 73.99% | 100.00% |
| Research & Development | 492.46K | 4.03M | 7.22M | 2.22M | 1.42M | 730.42K | 75.52K | 232.80K | 0.00 |
| General & Administrative | 0.00 | 937.17K | 776.62K | 672.35K | 331.42K | 584.95K | 68.69K | 39.50K | 30.45K |
| Selling & Marketing | 0.00 | 90.74K | 136.51K | 70.28K | 109.39K | 147.48K | 47.99K | 249.33K | 188.61K |
| SG&A | 1.47M | 2.04M | 3.22M | 1.94M | 1.46M | 865.91K | 842.21K | 288.83K | 219.07K |
| Other Expenses | 0.00 | 4.95M | 0.00 | 1.02M | 40.54K | 33.85K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.97M | 6.07M | 10.44M | 4.16M | 2.88M | 1.60M | 917.73K | 288.83K | 219.07K |
| Cost & Expenses | 2.06M | 6.12M | 10.50M | 4.22M | 2.94M | 1.65M | 960.71K | 298.72K | 219.07K |
| Interest Income | 178.94K | 107.53K | 68.45K | 27.65K | 35.73K | 85.44K | 417.00 | 418.00 | 25.00 |
| Interest Expense | 0.00 | 4.73K | 0.00 | 63.00 | 3.42K | 0.00 | 125.00 | 578.00 | 344.00 |
| Depreciation & Amortization | 91.34K | 57.85K | 64.92K | 61.41K | 56.66K | 55.21K | 42.98K | 9.89K | 103.07K |
| EBITDA | -1.80M | -5.96M | -10.37M | -3.12M | -2.81M | -1.60M | -917.19K | -288.67K | -319.00 |
| EBITDA Ratio | 0.00% | -122.48% | 0.00% | -434.12% | 0.00% | -4,716.06% | -3,178.18% | -759.58% | -188.85% |
| Operating Income | -2.06M | -6.12M | -10.50M | -4.22M | -2.94M | -1.65M | -960.71K | -298.72K | -219.07K |
| Operating Income Ratio | 0.00% | -123.65% | 0.00% | -440.53% | 0.00% | -4,879.14% | -3,327.02% | -785.59% | -188.85% |
| Total Other Income/Expenses | 168.94K | -4.85M | 68.45K | 87.04K | 72.86K | -75.07K | 417.00 | -418.00 | 115.68K |
| Income Before Tax | -1.89M | -6.02M | -10.44M | -3.18M | -2.87M | -1.69M | -960.30K | -299.14K | -103.39K |
| Income Before Tax Ratio | 0.00% | -121.58% | 0.00% | -331.45% | 0.00% | -5,000.92% | -3,325.59% | -786.70% | -89.13% |
| Income Tax Expense | -2.21M | -4.95M | -5.00 | 3.00 | -1.00 | -33.85K | -28.88K | -38.03K | -319.00 |
| Net Income | 324.21K | -1.07M | -10.44M | -3.18M | -2.87M | -1.66M | -931.42K | -261.12K | -103.39K |
| Net Income Ratio | 0.00% | -21.58% | 0.00% | -331.45% | 0.00% | -4,900.92% | -3,225.59% | -686.70% | -89.13% |
| EPS | 0.00 | -0.01 | -0.07 | -0.02 | -0.04 | -0.02 | -0.03 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | -0.07 | -0.02 | -0.04 | -0.02 | -0.03 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 144.51M | 143.47M | 143.47M | 143.47M | 78.38M | 71.53M | 30.94M | 73.58M | 73.58M |
| Weighted Avg Shares Out (Dil) | 144.51M | 143.47M | 143.47M | 143.47M | 78.38M | 71.53M | 30.94M | 73.58M | 73.58M |
Source: https://incomestatements.info
Category: Stock Reports